Seven for 7: Alexa sends the wrong message; does GDPR take us backwards? Uber crash – design flaw; future gazing with Michio Kaku; AI Winners; Ocado transformation and Energy Industry Updates.
(1) Amazon Echo: message in a bottle
The technology story of the week is undoubtedly the one about Amazon Echo and the message it inadvertently sent. ICMYI, a couple in Oregon had a call from an acquaintance to say that Alexa had sent them a recording of a private conversation of the couple, without their permission, or even knowledge. Amazon’s explanation is that this is the rare combination scenarios where a normal conversation between the couple somehow triggered all the keywords and responses that made Alexa record, validate and send the conversation to the acquaintance. This feels like the equivalent of the money, typewriter and Shakespeare problem, only, it’s not an infinite amount of time.
Here’s Amazon’s explanation: https://www.recode.net/2018/5/24/17391480/amazon-alexa-woman-secret-recording-echo-explanation
(2) GDPR – impact on marketing and innovation.
I’m sure you’ve all received hundreds of emails in the past week exhorting you to stay in touch and re-sign up for all the emails you’ve been getting from people you didn’t know were sending you emails. But now that the moment has come, how will marketing work in a GDPR world? In one way this will take marketing backwards – as there is now a ban on algorithmic decision making based on behavioural data. It’s a moot point whether advertising falls into this category but companies may want to play it safe and in any case, the confusion will create a speed breaker in the short term. We may now be back in the world where if you’re watching or reading about champions league football you will see a beer ad irrespective of who you are. Not just marketing – a lot of innovation will also come under fire – both because of safety first practices, but also because some organisations will use GDPR as a shield for enabling innovation stifling practices, as highlighted by John Battelle of NewCo Shift. He argues that the regulation favours ‘at scale first parties’ – large tech platforms that provide you with a direct service such as Netflix, Facebook, or Uber – where users are likely to still give consent for data use more readily than to smaller, upcoming or relatively new and unproven services.
Dipayan Ghosh in the HBR – GDPR & advertising: https://hbr.org/2018/05/how-gdpr-will-transform-digital-marketing
John Battelle on GDPR & Innovation: https://shift.newco.co/how-gdpr-kills-the-innovation-economy-844570b70a7a
(3) Driverless / Uber/ Analysis
The analysis of Uber’s recent driverless crash has now thrown some light on what went wrong. And the answers aren’t great for Uber. In a nutshell, the problem is design and not malfunction. Which means that all the components did exactly what they were designed to do. Nothing performed differently and no components were at fault for failing to do their job. But as a collective, the design itself was flawed. The car had 6 seconds and 378 feet of distance to do something about the pedestrian crossing the street with her cycle. But it was confused about what the object was. The human in the car only engaged the steering 1 second before the crash and started breaking 1 second after the collision. The car was not designed to warn the human driver about any possible threats. A lot of the inbuilt safety systems in the Volvo vehicle including tracking driver alertness, emergency braking and collision avoidance, were disabled in the autonomous mode. In a nutshell, the responsibility lies with Uber’s design of autonomous cars. Uber has stopped testing in Arizona but has now started exploring flying taxis. Not a project that might fill you with confidence!
Uber crash analysis: https://sf.curbed.com/2018/5/25/17395196/uber-report-preliminary-arizona-crash-fatal
(4) A glimpse of the future: Michio Kaku & Jack Ma
The robotics industry will take over the automobile industry. Your car will become a robot – you will argue with it. Then your brain will also be robotised and brain net will allow emotions and feelings to be uploaded. You will be able to mentally communicate with things around you. Biotech allows us to create skin, bone, cartilage and organs. Alcoholics may be able to replace their livers with artificial ones. You may be able to scan store goods with a contact lens and see the profit margin on goods. The first 7 mins of this video tells you all of this through the eyes and experience of futurist Michio Kaku. Jack Ma (14 mins in) also talks about trusting the next generation. And how we are transitioning from the industrial era where we made people behave like machines, to a world where we are making machines behave like people. Believe the future before you see it, to be a leader, according to Ma.
(5) Who’s Winning The AI Game?
With the whole world hurtling towards an AI future, this piece looks at who exactly wins the AI game – across 7 different layers. It won’t surprise you to know that China is making amazing gains as a nation – their face recognition can pick out a wanted man in a crowd of 50,000. But it might surprise you to note that Nvidia’s stock is up 1500% in the past 2 years on the back of the success of their GPU chips. Meanwhile, Google is giving away Tensorflow free. All this points to a $3.9 tn market for enterprise AI in 2022. Are you ready for the challenge?
Who wins AI, across 7 layers
(6) Ocado – digitally transformed.
When Ocado launched in 2000, it was on the heels of Webvan, a category of providers who set up to focus on eCommerce fulfilment, as an arm of Waitrose. Cut to 2018, and Ocado is a story of successful digital transformation. Ocado is today a provider of robotic technology for warehouse automation. Having become profitable in 2014, it now has a valuation of $5.3 bn and is set to become a part of the FTSE 100.
(7) Understanding statistics: What medical research reports miss
When a drug is tested and the outcome suggests a 5% chance of a possible side effect, this does not mean that you have a 5% chance of being impacted if the drug is administered to you. It means there is a 5% chance that you will have the condition which leads to you having a 100% likelihood of being impacted. This is a subtle but very important distinction in how we interpret the data. But continuing down this stream of thought, it points to the lack of personalisation of medicine, not just the misinterpretation of data.